Antepartum stillbirth rates during the COVID-19 pandemic in Austria: A population-based study.


Journal

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
ISSN: 1879-3479
Titre abrégé: Int J Gynaecol Obstet
Pays: United States
ID NLM: 0210174

Informations de publication

Date de publication:
Mar 2022
Historique:
received: 03 09 2021
accepted: 19 10 2021
pubmed: 21 10 2021
medline: 9 2 2022
entrez: 20 10 2021
Statut: ppublish

Résumé

The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 has had dramatic effects on the pregnant population worldwide, increasing the risk of adverse perinatal outcomes. To assess the incidence of antepartum stillbirth (aSB) during the COVID-19 pandemic in Austria. We collected epidemiological data from the Austrian Birth Registry and compared the rate of aSB (i.e., fetal death at or after 24 In total, 65 660 pregnancies were included, of which 171 resulted in aSB at 33.7 ± 4.8 gestational weeks. During the pandemic, the aSB rate increased from 2.49‰ to 2.60‰ (P = 0.601), in contrast to the significant decline in preterm deliveries at or before 37 gestational weeks from 0.61‰ to 0.56‰ (relative risk [RR] 0.93; 95% confidence interval [CI] 0.91-0.96; P < 0.001). During the first lockdown, the aSB rate significantly increased from 2.38‰ to 3.52‰ (P = 0.021), yielding an adjusted odds ratio of 1.57 (95% CI 1.08-2.27; P = 0.018). The event of aSB during the COVID-19 pandemic was strongly related with increased fetal weight and maternal obesity. In Austria, there has been an overall increase in the incidence of aSB during the pandemic with a significant peak during the first lockdown.

Sections du résumé

BACKGROUND BACKGROUND
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 has had dramatic effects on the pregnant population worldwide, increasing the risk of adverse perinatal outcomes.
OBJECTIVE OBJECTIVE
To assess the incidence of antepartum stillbirth (aSB) during the COVID-19 pandemic in Austria.
METHODS METHODS
We collected epidemiological data from the Austrian Birth Registry and compared the rate of aSB (i.e., fetal death at or after 24
RESULTS RESULTS
In total, 65 660 pregnancies were included, of which 171 resulted in aSB at 33.7 ± 4.8 gestational weeks. During the pandemic, the aSB rate increased from 2.49‰ to 2.60‰ (P = 0.601), in contrast to the significant decline in preterm deliveries at or before 37 gestational weeks from 0.61‰ to 0.56‰ (relative risk [RR] 0.93; 95% confidence interval [CI] 0.91-0.96; P < 0.001). During the first lockdown, the aSB rate significantly increased from 2.38‰ to 3.52‰ (P = 0.021), yielding an adjusted odds ratio of 1.57 (95% CI 1.08-2.27; P = 0.018). The event of aSB during the COVID-19 pandemic was strongly related with increased fetal weight and maternal obesity.
CONCLUSION CONCLUSIONS
In Austria, there has been an overall increase in the incidence of aSB during the pandemic with a significant peak during the first lockdown.

Identifiants

pubmed: 34669186
doi: 10.1002/ijgo.13989
pmc: PMC9087755
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

459-465

Informations de copyright

© 2021 The Authors. International Journal of Gynecology & Obstetrics published by John Wiley & Sons Ltd on behalf of International Federation of Gynecology and Obstetrics.

Références

Eur J Pediatr. 2021 Jun;180(6):1997-2002
pubmed: 33580293
BMJ. 2020 Jun 8;369:m2107
pubmed: 32513659
Arch Dis Child Fetal Neonatal Ed. 2021 Jul;106(4):456
pubmed: 33127736
Lancet Glob Health. 2021 Feb;9(2):e112
pubmed: 33227255
Int J Gynaecol Obstet. 2021 Dec;155(3):483-489
pubmed: 34287881
BMJ. 2020 Jul 27;370:m2915
pubmed: 32718946
PLoS One. 2021 Aug 20;16(8):e0254364
pubmed: 34415931
BMC Pregnancy Childbirth. 2021 Aug 26;21(1):587
pubmed: 34445988
Acta Obstet Gynecol Scand. 2021 Oct;100(10):1756-1770
pubmed: 34096034
JAMA. 2021 Jan 5;325(1):86-87
pubmed: 33284314
Int J Gynaecol Obstet. 2021 Feb;152(2):231-235
pubmed: 33128794
Lancet Infect Dis. 2020 Jun;20(6):652-653
pubmed: 32142639
Lancet Glob Health. 2021 Jun;9(6):e759-e772
pubmed: 33811827
Ann Intern Med. 2021 Jun;174(6):873-875
pubmed: 33428442
JAMA. 2020 Jul 10;:
pubmed: 32648892
Diagnostics (Basel). 2021 Jan 08;11(1):
pubmed: 33435547
Lancet Glob Health. 2021 Jan;9(1):e10-e11
pubmed: 33212029
Eur J Pediatr. 2021 Jun;180(6):2003-2004
pubmed: 33844050
Int J Gynaecol Obstet. 2022 Mar;156(3):459-465
pubmed: 34669186

Auteurs

Dana A Muin (DA)

Department of Obstetrics and Gynecology, Division of Feto-maternal Medicine, Medical University of Vienna, Vienna, Austria.

Sabrina Neururer (S)

Department of Clinical Epidemiology, Tyrolean Federal Institute for Integrated Care, Tirol Kliniken GmbH, Innsbruck, Austria.

Veronica Falcone (V)

Department of Obstetrics and Gynecology, Division of Feto-maternal Medicine, Medical University of Vienna, Vienna, Austria.

Karin Windsperger (K)

Department of Obstetrics and Gynecology, Division of Feto-maternal Medicine, Medical University of Vienna, Vienna, Austria.

Hanns Helmer (H)

Department of Obstetrics and Gynecology, Division of Feto-maternal Medicine, Medical University of Vienna, Vienna, Austria.

Hermann Leitner (H)

Department of Clinical Epidemiology, Tyrolean Federal Institute for Integrated Care, Tirol Kliniken GmbH, Innsbruck, Austria.

Herbert Kiss (H)

Department of Obstetrics and Gynecology, Division of Feto-maternal Medicine, Medical University of Vienna, Vienna, Austria.

Alex Farr (A)

Department of Obstetrics and Gynecology, Division of Feto-maternal Medicine, Medical University of Vienna, Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH